Patatin-Like Phospholipase Domain-Containing 3 and the Pathogenesis and Progression of Pediatric Nonalcoholic Fatty Liver Disease

Jeffrey D. Browning; Jonathan C. Cohen; Helen H. Hobbs

doi:10.1002/hep.23946

Patatin-Like Phospholipase Domain-Containing 3 and the Pathogenesis and Progression of Pediatric Nonalcoholic Fatty Liver Disease

Jeffrey D. Browning, Jonathan C. Cohen, Helen H. Hobbs

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1189-1192
Number of pages	4
Journal	Hepatology
Volume	52
Issue number	4
DOIs	https://doi.org/10.1002/hep.23946
State	Published - Oct 2010

ASJC Scopus subject areas

Hepatology

Access to Document

10.1002/hep.23946

Cite this

@article{fa12513ebe8c4332b4af7150400a7c92,

title = "Patatin-Like Phospholipase Domain-Containing 3 and the Pathogenesis and Progression of Pediatric Nonalcoholic Fatty Liver Disease",

author = "Browning, {Jeffrey D.} and Cohen, {Jonathan C.} and Hobbs, {Helen H.}",

note = "Funding Information: Abbreviations:: I148M, substitution of methionine for isoleucine at codon 148; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; PNPLA3, patatin-like phospholipase domain-containing 3. Supported by the following National Institutes of Health grants: 5K23DK074396 (to J.D.B.), and RL1HL092550 and PO1HL20948 (to H.H.H., J.C.C.). Address reprint requests to: Helen H. Hobbs, M.D.1,2, Department of Molecular Genetics, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX. E-mail: helen.hobbs@utsouthwestern.edu; fax: 214-648-7539. Copyright VC 2010 by the American Association for the Study of Liver Diseases. Published online in Wiley Online Library (wileyonlinelibrary.com). DOI 10.1002/hep.23946 Potential conflict of interest: Dr. Cohen is a consultant for Amgen and is on the speakers{\textquoteright} bureau of Merck and Pfizer. Dr. Hobbs is a consultant for Pfizer.",

year = "2010",

month = oct,

doi = "10.1002/hep.23946",

language = "English (US)",

volume = "52",

pages = "1189--1192",

journal = "Hepatology",

issn = "0270-9139",

publisher = "John Wiley and Sons Ltd",

number = "4",

}

TY - JOUR

T1 - Patatin-Like Phospholipase Domain-Containing 3 and the Pathogenesis and Progression of Pediatric Nonalcoholic Fatty Liver Disease

AU - Browning, Jeffrey D.

AU - Cohen, Jonathan C.

AU - Hobbs, Helen H.

N1 - Funding Information: Abbreviations:: I148M, substitution of methionine for isoleucine at codon 148; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; PNPLA3, patatin-like phospholipase domain-containing 3. Supported by the following National Institutes of Health grants: 5K23DK074396 (to J.D.B.), and RL1HL092550 and PO1HL20948 (to H.H.H., J.C.C.). Address reprint requests to: Helen H. Hobbs, M.D.1,2, Department of Molecular Genetics, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX. E-mail: helen.hobbs@utsouthwestern.edu; fax: 214-648-7539. Copyright VC 2010 by the American Association for the Study of Liver Diseases. Published online in Wiley Online Library (wileyonlinelibrary.com). DOI 10.1002/hep.23946 Potential conflict of interest: Dr. Cohen is a consultant for Amgen and is on the speakers’ bureau of Merck and Pfizer. Dr. Hobbs is a consultant for Pfizer.

PY - 2010/10

Y1 - 2010/10

UR - http://www.scopus.com/inward/record.url?scp=77957941549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957941549&partnerID=8YFLogxK

U2 - 10.1002/hep.23946

DO - 10.1002/hep.23946

M3 - Article

C2 - 20879029

AN - SCOPUS:77957941549

SN - 0270-9139

VL - 52

SP - 1189

EP - 1192

JO - Hepatology

JF - Hepatology

IS - 4

ER -

Patatin-Like Phospholipase Domain-Containing 3 and the Pathogenesis and Progression of Pediatric Nonalcoholic Fatty Liver Disease

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this